Market News
Senores Pharmaceuticals Share Price Highlights: Stock declines 6.3% after listing at 53.4% premium
.png)
4 min read | Updated on December 30, 2024, 15:40 IST
SUMMARY
Senores Pharmaceuticals IPO Listing, Share Price: Senores Pharmaceuticals shares were listed at ₹600 apiece on the National Stock Exchange (NSE) on Monday, a premium of 53.45% over the issue price of ₹391 apiece.
Stock list
Senores Pharmaceuticals IPO had a price range of ₹372-₹391 per share.
- Current price: ₹545.95 (-9%)
- Issue price: ₹391
- Open: ₹600
- High: ₹609.65
- Low: ₹538.85
- Swapnil Shah, Promoter and Managing Director
- Sanjay Majmudar, Chairman and Non-Executive, Non-Independent Director
- Ashok Barot, Promoter and Non-Executive, Non-Independent Director
- Jitendra Sanghvi, Non-Executive, Non-Independent Director
- Chetan Shah, Whole-Time Director and Chief Operating Officer
- Deval Shah, Whole-Time Director and Chief Financial Officer
- Hemanshu Pandya, Non-Executive, Non-Independent Director
- Arpit Shah, Non-Executive, Non-Independent Director
- Naresh Shah, Non-Executive, Independent Director
- Manjula Shroff, Non-Executive, Independent Director
- Kalpit Gandhi, Non-Executive, Independent Director
- Udayan Choksi, Non-Executive, Independent Director
- Set up a new manufacturing facility
- Repayment of loans
- Acquisitions and growth
- Working capital requirements
- General corporate purposes
- Traded volume: 107.79 lakh
- Traded value: ₹633.66 crore
- Market capitalisation: ₹2,565.18 crore
- Current price: ₹568 (-5.33%)
- Issue price: ₹391
- Open: ₹600
- High: ₹609.65
- Low: ₹566.20
| Category | Number of Times Subscription |
|---|---|
| Qualified Institutional Buyers (QIBs) | 94.66 |
| Non-institutional Investors (NIIs) | 96.30 |
| Retail | 90.46 |
| Total | 93.69 |
| Particulars | FY22 | FY23 | FY24 | Q1FY25 |
|---|---|---|---|---|
| Revenue | ₹14.17 cr | ₹35.34 cr | ₹214.52 cr | ₹181.02 cr |
| Net Profit | ₹0.99 cr | ₹8.44 cr | ₹32.71 cr | ₹23.94 cr |
Issue's book running lead manager
Equirus Capital, Ambit, Nuvama Wealth Management were the issue's lead book-running manager, while Link Intime India was the registrar.
The issue was open for subscription from December 20 to December 24. The allotment status was finalised on December 26. The Senores Pharmaceuticals share listing will occur on December 30
The company had set a price band of ₹372 to ₹391 per share.
Senores Pharmaceuticals IPO listing date and time
Shares of Senores Pharmaceuticals will be listed on the National Stock Exchange (NSE) and the BSE on Monday at 10 am.
Senores Pharmaceuticals develops and manufactures pharmaceutical products for the regulated markets of the UK, the US, and Canada. It also serves emerging markets.
About The Author
Next Story
